• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

盐酸曲马多液体固体致密制剂与市售缓释片体外溶出度曲线比较方法的评价

Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets.

作者信息

Karmarkar A B, Gonjari I D, Hosmani A H, Dhabale P N

机构信息

Govt. College of Pharmacy, Karad-415124, Dist. Satara, MS, India.

出版信息

Drug Discov Ther. 2010 Feb;4(1):26-32.

PMID:22491149
Abstract

The aim of the present work was to prepare and evaluate sustained release liquisolid compact formulations of tramadol hydrochloride. The dissolution profile of the prepared compacts was also compared to that of a marketed preparation. Liquisolid sustained release formulations were prepared by using HPMC K4M as a sustained release agent. Precompression studies of characteristics such as flow properties were also carried out. Liquisolid compacts were evaluated by hardness, friability, and in vitro dissolution studies. Comparison of dissolution profiles was carried out by using a modelindependent, model-dependent, and statistical approach. The prepared liquisolid compacts are new dosage forms with better sustained release behavior compared to a marketed sustained formulation. The dissolution profile followed the Peppas model as "best fit" model. Two-way ANOVA results revealed a significant difference in dissolution profiles. This systematic approach to producing a formulation was found to help with analyzing the sustained release of tramadol hydrochloride. The use and evaluation of model-dependent methods is more complicated. These methods provide an acceptable model approach that indicates the true relationship between percent drug release and time variables, including statistical assumptions.

摘要

本研究的目的是制备并评估盐酸曲马多的缓释液固型制剂。还将所制备制剂的溶出曲线与市售制剂的溶出曲线进行了比较。采用羟丙甲纤维素K4M作为缓释剂制备液固型缓释制剂。还进行了诸如流动性等特性的压片前研究。通过硬度、脆碎度和体外溶出研究对液固型片剂进行评估。采用非模型依赖、模型依赖和统计方法对溶出曲线进行比较。与市售缓释制剂相比,所制备的液固型片剂是具有更好缓释行为的新剂型。溶出曲线以Peppas模型作为“最佳拟合”模型。双向方差分析结果显示溶出曲线存在显著差异。发现这种制备制剂的系统方法有助于分析盐酸曲马多的缓释情况。模型依赖方法的使用和评估更为复杂。这些方法提供了一种可接受的模型方法,表明了药物释放百分比与时间变量之间的真实关系,包括统计假设。

相似文献

1
Evaluation of in vitro dissolution profile comparison methods of sustained release tramadol hydrochloride liquisolid compact formulations with marketed sustained release tablets.盐酸曲马多液体固体致密制剂与市售缓释片体外溶出度曲线比较方法的评价
Drug Discov Ther. 2010 Feb;4(1):26-32.
2
Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.液固技术作为一种从片剂基质中持续释放盐酸普萘洛尔的新方法。
Int J Pharm. 2008 Oct 1;362(1-2):102-8. doi: 10.1016/j.ijpharm.2008.06.022. Epub 2008 Jul 4.
3
Effect of solvent type on retardation properties of diltiazem HCl form liquisolid tablets.溶剂类型对盐酸地尔硫䓬的液体固体制剂的迟滞性质的影响。
Colloids Surf B Biointerfaces. 2014 Jan 1;113:10-4. doi: 10.1016/j.colsurfb.2013.08.017. Epub 2013 Aug 31.
4
Liquisolid compacts: the effect of cosolvent and HPMC on theophylline release.液固压缩片:共溶剂和 HPMC 对茶碱释放的影响。
Colloids Surf B Biointerfaces. 2010 Aug 1;79(1):262-9. doi: 10.1016/j.colsurfb.2010.04.008. Epub 2010 Apr 21.
5
Effects of liquisolid formulations on dissolution of naproxen.液固体制剂对萘普生溶出度的影响。
Eur J Pharm Biopharm. 2009 Nov;73(3):373-84. doi: 10.1016/j.ejpb.2009.08.002. Epub 2009 Aug 11.
6
Liquisolid technique to enhance and to sustain griseofulvin dissolution: effect of choice of non-volatile liquid vehicles.液质同载技术增强和维持灰黄霉素溶出度的研究:非挥发性液体载体选择的影响。
Int J Pharm. 2012 Sep 15;434(1-2):122-32. doi: 10.1016/j.ijpharm.2012.05.072. Epub 2012 Jun 5.
7
Liquisolid Tablets for Dissolution Enhancement of a Hypolipidemic Drug.用于增强降血脂药物溶出度的液固混合片
Indian J Pharm Sci. 2015 May-Jun;77(3):290-8. doi: 10.4103/0250-474x.159618.
8
The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts.载体的类型和浓度对难溶性药物(吲哚美辛)从液固分散体中的溶出速率的影响。
J Pharm Pharm Sci. 2005 Jan 12;8(1):18-25.
9
Enhancement of Loperamide Dissolution Rate by Liquisolid Compact Technique.通过液固压缩技术提高洛哌丁胺的溶解速率
Adv Pharm Bull. 2016 Sep;6(3):385-390. doi: 10.15171/apb.2016.050. Epub 2016 Sep 25.
10
Formulation factors affecting the release of ezetimibe from different liquisolid compacts.影响不同固体分散体中依泽替米贝释放的制剂因素。
Pharm Dev Technol. 2013 Mar-Apr;18(2):417-27. doi: 10.3109/10837450.2012.680594. Epub 2012 Apr 24.

引用本文的文献

1
Evaluation of the effect of carrier material on modification of release characteristics of poor water soluble drug from liquisolid compacts.评价载体材料对改善难溶性药物从液固体制剂中释放特性的影响。
PLoS One. 2021 Aug 2;16(8):e0249075. doi: 10.1371/journal.pone.0249075. eCollection 2021.
2
Liquisolid technique and its applications in pharmaceutics.液固技术及其在药剂学中的应用。
Asian J Pharm Sci. 2017 Mar;12(2):115-123. doi: 10.1016/j.ajps.2016.09.007. Epub 2016 Nov 4.
3
Pharmaceutical Dispersion Techniques for Dissolution and Bioavailability Enhancement of Poorly Water-Soluble Drugs.
用于提高难溶性药物溶出度和生物利用度的药物分散技术。
Pharmaceutics. 2018 Jun 23;10(3):74. doi: 10.3390/pharmaceutics10030074.
4
Newly developed controlled release subcutaneous formulation for tramadol hydrochloride.新开发的盐酸曲马多控释皮下制剂。
Saudi Pharm J. 2018 May;26(4):585-592. doi: 10.1016/j.jsps.2018.01.014. Epub 2018 Jan 31.
5
Sustained-release liquisolid compact tablets containing artemether-lumefantrine as alternate-day regimen for malaria treatment to improve patient compliance.含有蒿甲醚-本芴醇的缓释液固复合片作为疟疾治疗的隔日疗法,以提高患者的依从性。
Int J Nanomedicine. 2016 Nov 28;11:6365-6378. doi: 10.2147/IJN.S92755. eCollection 2016.
6
Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations.布地奈德复溶的立体稳定磷脂纳米胶束用于雾化:理化性质表征和体内外评价。
Int J Nanomedicine. 2011;6:2351-66. doi: 10.2147/IJN.S25363. Epub 2011 Oct 14.